These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

283 related items for PubMed ID: 19359089

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. The influence of pNx/pN0 grouping in a multivariate setting for outcome modeling in patients with clear cell renal cell carcinoma.
    Ward JF, Blute ML, Cheville JC, Lohse CM, Weaver AL, Zincke H.
    J Urol; 2002 Jul; 168(1):56-60. PubMed ID: 12050492
    [Abstract] [Full Text] [Related]

  • 24. Elective nephron sparing surgery for renal cell carcinoma larger than 4 cm.
    Pahernik S, Roos F, Röhrig B, Wiesner C, Thüroff JW.
    J Urol; 2008 Jan; 179(1):71-4; discussion 74. PubMed ID: 17997423
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Features associated with recurrence beyond 5 years after nephrectomy and nephron-sparing surgery for renal cell carcinoma: development and internal validation of a risk model (PRELANE score) to predict late recurrence based on a large multicenter database (CORONA/SATURN Project).
    Brookman-May S, May M, Shariat SF, Xylinas E, Stief C, Zigeuner R, Chromecki T, Burger M, Wieland WF, Cindolo L, Schips L, De Cobelli O, Rocco B, De Nunzio C, Feciche B, Truss M, Gilfrich C, Pahernik S, Hohenfellner M, Zastrow S, Wirth MP, Novara G, Carini M, Minervini A, Simeone C, Antonelli A, Mirone V, Longo N, Simonato A, Carmignani G, Ficarra V, Members of the CORONA project and the SATURN project.
    Eur Urol; 2013 Sep; 64(3):472-7. PubMed ID: 22748912
    [Abstract] [Full Text] [Related]

  • 31. Does the size of the surgical margin in partial nephrectomy for renal cell cancer really matter?
    Sutherland SE, Resnick MI, Maclennan GT, Goldman HB.
    J Urol; 2002 Jan; 167(1):61-4. PubMed ID: 11743276
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Lack of retroperitoneal lymphadenopathy predicts survival of patients with metastatic renal cell carcinoma.
    Vasselli JR, Yang JC, Linehan WM, White DE, Rosenberg SA, Walther MM.
    J Urol; 2001 Jul; 166(1):68-72. PubMed ID: 11435825
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. The role of nephron sparing surgery for metastatic (pM1) renal cell carcinoma.
    Krambeck AE, Leibovich BC, Lohse CM, Kwon ED, Zincke H, Blute ML.
    J Urol; 2006 Nov; 176(5):1990-5; discussion 1995. PubMed ID: 17070231
    [Abstract] [Full Text] [Related]

  • 38. Radical nephrectomy for pT1a renal masses may be associated with decreased overall survival compared with partial nephrectomy.
    Thompson RH, Boorjian SA, Lohse CM, Leibovich BC, Kwon ED, Cheville JC, Blute ML.
    J Urol; 2008 Feb; 179(2):468-71; discussion 472-3. PubMed ID: 18076931
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.